Inotiv (NOTV)
(Real Time Quote from BATS)
$1.97 USD
+0.02 (1.03%)
Updated Jul 22, 2024 02:52 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NOTV 1.97 +0.02(1.03%)
Will NOTV be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for NOTV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NOTV
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Misses Revenue Estimates
Inotiv (NOTV) Is a Great Choice for 'Trend' Investors, Here's Why
NOTV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Fast-paced Mover Inotiv (NOTV) Is a Great Choice for Value Investors
Is Inotiv (NOTV) a Great Value Stock Right Now?
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?
Other News for NOTV
Inotiv (NOTV) Gets a Buy from Craig-Hallum
Analysts Offer Insights on Healthcare Companies: Semler Scientific (SMLR) and Inotiv (NOTV)
Inotiv (NOTV) Receives a Buy from Craig-Hallum
Inotiv, Inc. Provides Business Updates
Inotiv provides business updates